|
1
|
Iseme RA, McEvoy M, Kelly B, Agnew L,
Walker FR and Attia J: Is osteoporosis an autoimmune mediated
disorder? Bone Rep. 7:121–131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Phetfong J, Sanvoranart T, Nartprayut K,
Nimsanor N, Seenprachawong K, Prachayasittikul V and Supokawej A:
Osteoporosis: The current status of mesenchymal stem cell-based
therapy. Cell Mol Biol Lett. 21:122016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oryan A, Kamali A, Moshiri A and Baghaban
Eslaminejad M: Role of mesenchymal stem cells in bone regenerative
medicine: What is the evidence? Cells Tissues Organs. 204:59–83.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shen Y, Liu S, Fan J, Jin Y, Tian B, Zheng
X and Fu H: Nuclear retention of the lncRNA SNHG1 by doxorubicin
attenuates hnRNPC-p53 protein interactions. EMBO Rep. 18:536–548.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang CG, Liao Z, Xiao H, Liu H, Hu YH,
Liao QD and Zhong D: LncRNA KCNQ1OT1 promoted BMP2 expression to
regulate osteogenic differentiation by sponging miRNA-214. Exp Mol
Pathol. 107:77–84. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao Y, Xiao F, Wang C, Wang C, Cui P,
Zhang X and Chen X: Long noncoding RNA MALAT1 promotes osterix
expression to regulate osteogenic differentiation by targeting
miRNA-143 in human bone marrow-derived mesenchymal stem cells. J
Cell Biochem. 119:6986–6996. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun Y, Wei G, Luo H, Wu W, Skogerbø G, Luo
J and Chen R: The long noncoding RNA SNHG1 promotes tumor growth
through regulating transcription of both local and distal genes.
Oncogene. 36:6774–6783. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu M, Chen X, Lin K, Zeng K, Liu X, Pan B,
Xu X, Xu T, Hu X, Sun L, et al: The long noncoding RNA SNHG1
regulates colorectal cancer cell growth through interactions with
EZH2 and miR-154-5p. Mol Cancer. 17:1412018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cui Y, Zhang F, Zhu C, Geng L, Tian T and
Liu H: Upregulated lncRNA SNHG1 contributes to progression of
non-small cell lung cancer through inhibition of miR-101-3p and
activation of Wnt/β-catenin signaling pathway. Oncotarget.
8:17785–17794. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang Y, Wu W, Jiao G, Chen Y and Liu H:
LncRNA SNHG1 modulates p38 MAPK pathway through Nedd4 and thus
inhibits osteogenic differentiation of bone marrow mesenchymal stem
cells. Life Sci. 228:208–214. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oliveto S, Mancino M, Manfrini N and Biffo
S: Role of microRNAs in translation regulation and cancer. World J
Biol Chem. 8:45–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Meng Y, Cui Q, Qin F, Yang H, Chen
Y, Cheng Y, Shi J and Guo Y: MiR-101 targets the EZH2/Wnt/β-catenin
the pathway to promote the osteogenic differentiation of human bone
marrow-derived mesenchymal stem cells. Sci Rep. 6:369882016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng R, Zhang J and Chen J: lncRNA SNHG1
negatively regulates miRNA-101-3p to enhance the expression of
ROCK1 and promote cell proliferation, migration and invasion in
osteosarcoma. Int J Mol Med. 43:1157–1166. 2019.PubMed/NCBI
|
|
14
|
Yavropoulou MP and Yovos JG: The role of
the Wnt signaling pathway in osteoblast commitment and
differentiation. Hormones (Athens). 6:279–294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Albers J, Keller J, Baranowsky A, Beil FT,
Catala-Lehnen P, Schulze J, Amling M and Schinke T: Canonical Wnt
signaling inhibits osteoclastogenesis independent of
osteoprotegerin. J Cell Biol. 200:537–549. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Lu W, King TD, Liu CC, Bijur GN and
Bu G: Dkk1 stabilizes Wnt co-receptor LRP6: Implication for Wnt
ligand-induced LRP6 down-regulation. PLoS One. 5:e110142010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mirfazeli ES, Arefian E, Nadri S,
Rezazadeh Valojerdi R, Kehtari M and Zeynali B: DKK1 expression is
suppressed by miR-9 during induced dopaminergic differentiation of
human trabecular meshwork mesenchymal stem cells. Neurosci Lett.
707:1342502019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sözen T, Özışık L and Başaran NÇ: An
overview and management of osteoporosis. Eur J Rheumatol. 4:46–56.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou DA, Zheng HX, Wang CW, Shi D and Li
JJ: Influence of glucocorticoids on the osteogenic differentiation
of rat bone marrow-derived mesenchymal stem cells. BMC
Musculoskelet Disord. 15:2392014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang C, Meng H, Wang X, Zhao C, Peng J and
Wang Y: Differentiation of bone marrow mesenchymal stem cells in
osteoblasts and adipocytes and its role in treatment of
osteoporosis. Med Sci Monit. 22:226–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu Y, Qin W, Guo D, Liu J, Zhang M and Jin
Z: LncRNA-TWIST1 promoted osteogenic differentiation both in
PPDLSCs and in HPDLSCs by inhibiting TWIST1 expression. Biomed Res
Int. 2019:87359522019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang S, Xie Z, Wang P, Li J, Wang S, Liu
W, Li M, Wu X, Su H, Cen S, et al: LncRNA-OG promotes the
osteogenic differentiation of bone marrow-derived mesenchymal stem
cells under the regulation of hnRNPK. Stem Cells. 37:270–283. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gong YY, Peng MY, Yin DQ and Yang YF: Long
non-coding RNA H19 promotes the osteogenic differentiation of rat
ectomesenchymal stem cells via Wnt/β-catenin signaling pathway. Eur
Rev Med Pharmacol Sci. 22:8805–8813. 2018.PubMed/NCBI
|
|
25
|
Du Z, Sun T, Hacisuleyman E, Fei T, Wang
X, Brown M, Rinn JL, Lee MG, Chen Y, Kantoff PW and Liu XS:
Integrative analyses reveal a long noncoding RNA-mediated sponge
regulatory network in prostate cancer. Nat Commun. 7:109822016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang D, Wei Y, Zhu J and Wang F: Long
non-coding RNA SNHG1 functions as a competitive endogenous RNA to
regulate PDCD4 expression by sponging miR-195-5p in hepatocellular
carcinoma. Gene. 714:1439942019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lan X and Liu X: LncRNA SNHG1 functions as
a ceRNA to antagonize the effect of miR-145a-5p on the
down-regulation of NUAK1 in nasopharyngeal carcinoma cell. J Cell
Mol Med. 23:2351–2361. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, Cao L, Wu J and Wang Q: Long
non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326
and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88.
2018.PubMed/NCBI
|
|
29
|
Shen JJ, Zhang CH, Chen ZW, Wang ZX, Yang
DC, Zhang FL and Feng KH: LncRNA HOTAIR inhibited osteogenic
differentiation of BMSCs by regulating Wnt/β-catenin pathway. Eur
Rev Med Pharmacol Sci. 23:7232–7246. 2019.PubMed/NCBI
|
|
30
|
Li N, Ma Y, Wang W, Yin CC, Wu W, Sun R,
Zhao G, Li S and Wang X: LOC101928834, a novel lncRNA in
Wnt/β-catenin signaling pathway, promotes cell proliferation and
predicts poor clinical outcome in myelodysplastic syndromes. Clin
Sci (Lond). 134:1279–1293. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang K, Tian N, Liu H, Tao XZ, Wang MX and
Huang W: LncRNAp21 promotes osteogenic differentiation of
mesenchymal stem cells in the rat model of osteoporosis by the
Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci.
23:4303–4309. 2019.PubMed/NCBI
|
